SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > All Processing News

California bill would require Big Pharma to unveil how drugs are priced

26-Feb-2015 - A new California bill introduced earlier this week would, for the first time, require pharma companies to unveil a number of unique operational costs as a way to better understand drug pricing.

FTC requires Novartis to divest two potential cancer drugs to Array as part of GSK deal

24-Feb-2015 - In order to close Novartis’ $16bn purchase of GlaxoSmithKline’s portfolio of cancer treatments , the FTC (Federal Trade Commission) is requiring Novartis to divest all assets related to its potential BRAF and MEK inhibitor drugs to settle anticompetitive charge.

Fresenius Kabi sells cancer compounding biz to NewCo Pharma

17-Feb-2015 - Fresenius Kabi has sold its cancer drug pharmacy network CFL GmbH to NewCo Pharma GmbH five years after spending €42m to buy compounding capacity in Germany.

survey

Ever wanted to buy catalysts on your iPhone? Now you can thanks to Johnson Matthey

16-Feb-2015 - Quick question for chemists: Have you ever wanted to research chemical reactions and buy catalysts on your mobile phone? 

News in brief

London calling: Gilead to expand operations in UK capital

11-Feb-2015 - Gilead Sciences has committed S20m (€18m) to expand its presence in the UK and will double its workforce in the country.

Dispatches from BIO CEO 2015

Pfizer CEO slams US tax code, calls for more industry consolidation

11-Feb-2015 - In a wide-ranging interview that included his take on competition from Google and R&D spending, Pfizer CEO Ian Read offered a number of clues as to where his company is headed.

Pfizer 'comfortable' with Hospira's manufacturing network after quality review

09-Feb-2015 - Pfizer visited three troubled facilities in Hospira’s manufacturing network before entering a $17bn definitive merger agreement, the company says.

UPDATE

Novartis: New cost-saving unit will not target manufacturing network

29-Jan-2015 - Novartis has divested, restructured, or mothballed 24 manufacturing plants since 2010 but says its new NBS cost-saving business will not focus on streamlining and consolidating sites.

Hospira 'committed to quality' as total recall count hits 40 since 2012

27-Jan-2015 - A human hair found in a vial of Sodium Chloride Injection has led to the fortieth recall in three years for Hospira.

Halal and Kosher stamps of approval for pregnancy drug

26-Jan-2015 - A morning sickness drug made by Duchesnay USA will now display Halal and Kosher symbols – a move the company said is the first case of Kosher certification for an oral prescription drug in the US.

Teva: More biomanufacturing space needed to tap biologics opportunities

21-Jan-2015 - Teva must invest in its biomanufacturing network as the firm’s biologics aspirations grow beyond biosimilars, CEO Erez Vigodman told investors.

Cost, not compliance, behind Clayton closure, says Hospira

19-Jan-2015 - Hospira has announced it will close its plant in Clayton, North Carolina that it no longer deems cost effective for drug production.  

Novartis to close Puerto Rico plant and outsource to Eli Lilly

19-Jan-2015 - Novartis will close an OTC plant in Puerto Rico by 2019 and transfer manufacturing and packaging actives to sites in the US and facilities operated by Eli Lilly and Virbac.

J&J to receive almost €50m in grants to help manufacture Ebola vaccines

19-Jan-2015 - EFPIA has given J&J subsidiary Crucell Holland and partner Bavarian Nordic €47.6m ($54.9m) to accelerate development of an candidate Ebola vaccine.

Fresenius Kabi NY aseptic plant upgraded by USFDA

15-Jan-2015 - A Fresenius Kabi plant in New York has been upgraded, and up to five new products could receive FDA approval, almost three years after receiving a warning letter.

Ocean rises for drug transportation due to cost and cold chain concerns

15-Jan-2015 - AstraZeneca and Baxter are opting to transport pharmaceuticals by ocean and land routes as costs and cold chain security drive a drop in air freight.

US solvent disposal definition will encourage recycling, says SOCMA

14-Jan-2015 - Critical solvents used by the pharmaceutical manufacturers have been excluded from the EPA's final ruling on waste disposal, in a move welcomed by a US industry group.

Micronization getting bigger: Fareva invests in capacity citing increasing demand

13-Jan-2015 - Fareva has added extra micronization capacity citing growing demand and the opportunity to work with customers earlier in the development process as the driver for the investment.

US FDA approves Impax’s Parkinson’s disease treatment following resolved manufacturing issues

12-Jan-2015 - Almost two years since it was first rejected , Impax Pharmaceuticals said late last week that the US FDA has approved Rytary, an extended-release oral capsule formulation of carbidopa-levodopa, for the treatment of Parkinson's disease.

Shire takes $5bn gamble on NPS' hormone replacement PDUFA decision

12-Jan-2015 - Shire says its $5.2bn (€4.4bn) acquisition of NPS Pharmaceuticals is a calculated risk, coming just days before the US FDA decides whther to approve the hormone replacement therapy Natpara.

Argos looks to disposables for manufacturing personalized immunotherapies

07-Jan-2015 - Cancer and infectious disease immunotherapy developer Argos Therapeutics is collaborating with Saint-Gobain’s Performance Plastics division, to design, integrate and scale production of a range of disposables for use in the manufacturing of Argos’ lead product candidate.

Sartorius sells Intec to focus on bioprocessing and lab

05-Jan-2015 - Sartorius AG has announced plans to sell its industrial weighing and control tech business, Intec, as part of a long-term strategy to focus on bioprocessing and laboratory equipment.

Professional liaisons: ‘Tinder for healthcare’ shakes up conferences

05-Jan-2015 - Mobile software modelled on the dating app Tinder could help life science investors find new partners according to networking firm PostHealthcare.

Interactive Quiz!

The Big Pharma Big Quiz of the year, 2014

23-Dec-2014 - The year is over so time to reflect on who bought who, who sued who and who had what approved in our 2014 review quiz.

AstraZeneca API plant set to shut by 2017 as Patent Cliff strikes again

18-Dec-2014 - An AstraZeneca API plant in Bristol, UK will close its doors within two years due to patent expirations of its cholesterol-lowering blockbuster Crestor.

Spotlight

Third time's a charm: Pfizer to buy Hospira for $17bn
breaking news

Third time's a charm: Pfizer to buy Hospira for $17bn

Pfizer has entered into a definitive merger agreement to buy Hospira for $17bn.

Vertellus buys antiretroviral API reagent plant from Dow

Vertellus buys antiretroviral API reagent plant from Dow

Specialty chemicals firm Vertellus will continue to supply antiretroviral drugmakers sodium borohydride following its takeover of a...

ScinoPharm: profits fall on higher costs, an idle plant and lower Qsymia sales

ScinoPharm: profits fall on higher costs, an idle plant and lower Qsymia sales

ScinoPharm was hurt by weak US demand for the weight loss pill Qsymia, higher raw material prices...

Analyst: Pfizer's withdrawal from Repligen deal "not smart" amid growing Big Pharma interest in SMA

Analyst: Pfizer's withdrawal from Repligen deal "not smart" amid growing Big Pharma interest in SMA

Pfizer must act fast to convince investors it can compete with Roche and Biogen Idec for a...

MUGAS-funded Tamiflu analysis included fewer studies than Cochrane review

MUGAS-funded Tamiflu analysis included fewer studies than Cochrane review

Researchers claiming Tamiflu cuts flu symptom duration and hospitalisations analysed less than half as many studies as...

Key Industry Events

 

Access all events listing

Our events, Shows & Conferences...